Represented a pharmaceutical company before FTC regarding antitrust review of merger with another pharmaceutical company and negotiation of consent with FTC.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Domain name dispute actions for multiple representative clients
The firm represented numerous trademark owners in domain name dispute actions arising under the Anti-Cybersquatting Consumer Protection Act and under more
Restrictive covenant litigation for EyeWonder in New York federal court and in arbitration

The firm served as lead counsel for EyeWonder, Inc. in the Southern District of New York to enforce restrictive covenants when its former head of more

Listing of company on the NASDAQ OMX Stockholm
Advised in connection with the listing of a Swedish company on the  NASDAQ OMX Stockholm.  The firm also represented the company in the acquisition more
Appellate litigation services on a notable press rights decision
Led the appellate effort on a notable press rights decision for a large media company, where a federal, common law right was recognized to shield more